Open access
Aug 2026
Population pharmacogenomics in Russia: insights from 6102 exomes and implications for genomic medicine
WES is confirmed as a robust and scalable platform for population-level pharmacogenomic screening and broader clinical genomic applications, while demonstrating that haplotype-based imputation cannot fully overcome the intrinsic limitations of exome sequencing for comprehensive pharmacogenomic profiling.
A. Buianova, V. Cheranev, A. Shmitko et al.
· Human Genomics · 0 citations